GE HealthCare's Q1 2025 Revenue Surges to $4.8 Billion, Ranked 175th in Daily Trading Volume

On May 1, 2025, GE's trading volume was $555 million, a 38.41% decrease from the previous day, ranking 175th in the day's stock market. GE HealthCare (GEHC) fell by 3.78%.

GE HealthCare reported its first-quarter 2025 financial results, with net income attributable to the company reaching $564 million, up from $374 million in the prior year. Adjusted EBIT was $715 million, compared to $681 million in the previous year.

In the first quarter of 2025, GE HealthCare's revenue increased by 3% to $4.8 billion, driven by a 10% organic order growth. The company's net income also rose to $564 million. The acquisition of certain assets contributed to this growth.

GE HealthCare reported adjusted earnings per share of $1.01 on revenue that increased 3% year-over-year to $4.78 billion. The company's revenue growth was driven by strong demand for its medical devices and diagnostic imaging equipment.

GE HealthCare's revenue for the first quarter of 2025 was $4.8 billion, with a 4% organic growth. The adjusted EBIT margin was 15%, up 30 basis points year over year. Adjusted EPS was $1.01, up 12% year over year.

GE HealthCare exceeded first-quarter 2025 expectations with significant revenue and EPS gains. Despite a downward revision in EPS forecast, the company's performance was driven by strong demand for its medical devices and diagnostic imaging equipment.